• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Abbott launches over-the-counter continuous glucose monitor in the US

cafead

Administrator
Staff member
  • cafead   Sep 05, 2024 at 11:32: AM
via Abbott (ABT.N), opens new tab has launched its over-the-counter continuous glucose monitoring system Lingo in the U.S., days after a rival started marketing its product.

Lingo is available for consumers 18 years and older not on insulin in three payment options - $49 for two weeks, $89 for four weeks and $249 for 12 weeks, the company said on Thursday.

article source
 

<